346 related articles for article (PubMed ID: 11941958)
1. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
2. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
3. Morphological changes of early human hepatocarcinogenesis.
Hytiroglou P
Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
[TBL] [Abstract][Full Text] [Related]
4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
5. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
7. Expression of sialyl Lewis(x) in hepatocellular carcinoma.
Tori A; Harada A; Nakao A; Nonami T; Ito M; Takagi H
Hepatogastroenterology; 1995; 42(6):939-43. PubMed ID: 8847049
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
9. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
[TBL] [Abstract][Full Text] [Related]
10. E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma.
Zhang BH; Chen H; Yao XP; Cong WM; Wu MC
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):80-2. PubMed ID: 14607629
[TBL] [Abstract][Full Text] [Related]
11. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.
Nakamori S; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Iwanaga T; Matsushita Y; Irimura T
Cancer Res; 1993 Aug; 53(15):3632-7. PubMed ID: 8101764
[TBL] [Abstract][Full Text] [Related]
14. [E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma].
Zhang B; Chen H; Yao X; Cong W; Wu M
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):534-6. PubMed ID: 11832103
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix composition and integrin expression in early hepatocarcinogenesis in human cirrhotic liver.
Le Bail B; Faouzi S; Boussarie L; Balabaud C; Bioulac-Sage P; Rosenbaum J
J Pathol; 1997 Mar; 181(3):330-7. PubMed ID: 9155721
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis of hepatocellular nodular lesions.
Hytiroglou P; Theise ND
Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
[TBL] [Abstract][Full Text] [Related]
19. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
Wells SJ; DeRose PB; Cohen C
Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
[TBL] [Abstract][Full Text] [Related]
20. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]